Igc Pharma, Inc. (IGC) — 10-Q Filings
All 10-Q filings from Igc Pharma, Inc.. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (6)
-
IGC Pharma's Losses Widen Amidst R&D Surge and Revenue Drop
— Nov 14, 2025 Risk: high
IGC Pharma, Inc. reported a net loss of $1.821 million for the three months ended September 30, 2025, compared to a net loss of $1.717 million for the same peri -
IGC Pharma Narrows Q1 Loss to $1.6M, Boosts Cash with Stock Sale
— Aug 14, 2025 Risk: high
IGC Pharma, Inc. reported a net loss of $1.599 million for the three months ended June 30, 2025, an improvement from the $2.378 million net loss in the same per -
IGC Pharma Files Q3 2024 10-Q
— Feb 14, 2025 Risk: low
IGC Pharma, Inc. filed its quarterly report for the period ended December 31, 2024. The company, formerly known as India Globalization Capital, Inc., is incorpo -
IGC Pharma Files 10-Q for Q3 2024
— Nov 12, 2024 Risk: medium
IGC Pharma, Inc. filed its 10-Q for the quarterly period ended September 30, 2024. The company, formerly known as India Globalization Capital, Inc., is incorpor -
IGC Pharma Files Q2 2024 Report
— Aug 7, 2024 Risk: medium
IGC Pharma, Inc. filed its quarterly report for the period ending June 30, 2024. The company, formerly known as India Globalization Capital, Inc., is incorporat -
IGC Pharma, Inc. Files Quarterly Report on Form 10-Q for Period Ended December 31, 2023
— Feb 14, 2024 Risk: low
IGC Pharma, Inc. (IGC) filed a Quarterly Report (10-Q) with the SEC on February 14, 2024. IGC Pharma, Inc. filed its Form 10-Q for the quarterly period ended De
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX